Overview
Natalie Grover is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Grover is currently accepting new patients.
Her clinical research consists of co-authoring 69 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
The Moses H Cone Memorial Hospital Operating Corporation
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
Rex Hospital Inc
Robert Wehbie is a Hematologist Oncology specialist and an Infectious Disease provider in Raleigh, North Carolina. Dr. Wehbie is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Familial Pancreatic Cancer, Acute Mountain Sickness, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Wehbie is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Hodgkin LymphomaDr. Grover isElite. Learn about Hodgkin Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Grover isElite. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)
- Non-Hodgkin LymphomaDr. Grover isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- B-Cell LymphomaDr. Grover isDistinguished. Learn about B-Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Grover isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Grover isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Advanced
- Anaplastic Large Cell LymphomaDr. Grover isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Bone Marrow AspirationDr. Grover isAdvanced. Learn about Bone Marrow Aspiration.
- Follicular LymphomaDr. Grover isAdvanced. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Grover isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Grover isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Grover isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Grover isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaDr. Grover isExperienced. Learn about Burkitt Lymphoma.
